Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Route of Administration of Anti-IL5 Monoclonal Antibody in Prednisone-dependent Eosinophilic Asthma

NCT02559791 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT02559791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02559791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Route of Administration of Anti-IL5 Monoclonal Antibody in Prednisone-dependent Eosinophilic Asthma
Lead sponsor
McMaster University
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2015
Completion date
August 31, 2017
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic bronchitis, severe persistent asthma